Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney de Novo Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00504543
What this trial is testing

Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 311
Testing effectiveness (Phase 2)Study completedNCT00027820
What this trial is testing

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more
Fred Hutchinson Cancer Center 106
Testing effectiveness (Phase 2)Study completedNCT01596062
What this trial is testing

Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 16
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Post-approval studies (Phase 4)Study completedNCT00343226
What this trial is testing

An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.

Who this might be right for
Liver Transplantation
Novartis 48
Large-scale testing (Phase 3)Study completedNCT01079143
What this trial is testing

Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients

Who this might be right for
Renal Interstitial Fibrosis
Novartis Pharmaceuticals 194
Post-approval studies (Phase 4)Study completedNCT00369161
What this trial is testing

A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 228
Large-scale testing (Phase 3)Study completedNCT01187953
What this trial is testing

Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx

Who this might be right for
Renal Failure
Veloxis Pharmaceuticals 543
Post-approval studies (Phase 4)Study completedNCT00862979
What this trial is testing

A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients

Who this might be right for
Heart Transplantation
Novartis Pharmaceuticals 162
Testing effectiveness (Phase 2)UnknownNCT00890253
What this trial is testing

Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation

Who this might be right for
Liver TransplantationChronic Renal Insufficiency
Armin Goralczyk 29
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Large-scale testing (Phase 3)Ended earlyNCT03995901
What this trial is testing

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

Who this might be right for
Transplanted Organ Rejection
Talaris Therapeutics Inc. 15
Large-scale testing (Phase 3)Study completedNCT00239070
What this trial is testing

Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 69
Post-approval studies (Phase 4)Study completedNCT00266123
What this trial is testing

Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 420
Post-approval studies (Phase 4)UnknownNCT00693446
What this trial is testing

Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids

Who this might be right for
Pancreas TransplantationKidney Transplantation
Nantes University Hospital 118
Large-scale testing (Phase 3)Study completedNCT00149903
What this trial is testing

Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients

Who this might be right for
Renal Transplant
Novartis Pharmaceuticals 300
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06751602
What this trial is testing

Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Who this might be right for
Rejection Chronic Renal
The Methodist Hospital Research Institute 40
Post-approval studies (Phase 4)Study completedNCT00419926
What this trial is testing

Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis 313
Testing effectiveness (Phase 2)Study completedNCT01064791
What this trial is testing

Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 298
Post-approval studies (Phase 4)Looking for participantsNCT05242315
What this trial is testing

Extended-Release Tacrolimus Following Liver Transplantation

Who this might be right for
Liver Transplant; ComplicationsRenal InsufficiencyImmunosuppressant Adverse Reaction+2 more
University of Alberta 94
Next Page